阿米卡星血药浓度对呼吸道感染菌耐药性的影响

王传海; 张业新; 耿朝晖; 王传海; 张业新; 耿朝晖

[2] Hosokawa H,Nyu S,Nakamura K,et al.Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression[J].Chronobiol Int,1993,10(4):259-270.

[2]

Donald PR,Sirgel FA,Venter A,et al.The early bactericidal activity of amikacin in pulmonary tuberculosis[J].Int J Tuberc Lung Dis,2001,5(6):533-538.

[3] Fujimura A,Sudoh T,Ebihara A.Timedependent change in the toxic effects of amikacin on renal functions[J].Life Sci,1994,55(5):367-372.

[4] Belfayol L,Talon P,Eveillard M,et al.Pharmacokinetics of oncedaily amikacin in paediatric patients[J].Clin Microbiol Infect,1996,2(3):186-189.

[5] 毛耀南,钱南萍.微生物法测定硫酸阿米卡星血药浓度[J].现代医药卫生,2007,23(7):1051-1052.

[6] 陈海燕,何威.阿米卡星在老年呼吸系统感染患者体内的药动学研究[J].中国药房,2004,15(1):39-40.

[7] 董烽.硫酸阿米卡星注射液的合理给药[J].西部医学,2006,18(6):815-816.

[8] 张国俊,刘景春,张淑彩.院内获得性支气管肺部感染的病原学及药敏分析[J].中华医院感染学杂志,2000,10(4):309-310.

[9] 李云,王惠萱,张悦,等.164株鲍曼不动杆菌的感染及耐药性分析[J].实用医学杂志,2005,21(13):1471-1472.

[10] 卢亚林,游升荣,祁朝玲,等.93株铜绿假单胞菌-内酰胺酶检出情况及药敏分析[J].临床医药杂志,2003,16(3):25-27.